Humate-p 600 unit VWF:rcos
Ended Awarded
- Contract number
- SPE2DB25FYX14
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,742
Award facts
- Contract value 100% obligated
- $2,741.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,741.76 by the Defense Logistics Agency (DLA) on July 16, 2025, for the supply of HUMATE-P 600 Unit VWF:RCOS. This delivery order, which carries no set-aside designation, is scheduled for ultimate completion by August 6, 2025, and represents a specific product requisition under DMS Pharmaceutical Group's larger relationship with DLA. The award was issued to the place of performance in Park Ridge, Illinois, where the vendor maintains its primary operations.
This delivery order is issued under DMS Pharmaceutical Group's significant Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and extending through November 2026. The parent IDC authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal procurement markets while providing direct distribution of prescription drugs and specialty pharmaceutical products to military health systems.
Quick answers
Who was awarded contract SPE2DB25FYX14?
SPE2DB25FYX14 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 16, 2025.
How much is contract SPE2DB25FYX14 worth?
The government has obligated $2,742 on SPE2DB25FYX14.
Is contract SPE2DB25FYX14 an order under another contract?
Yes. SPE2DB25FYX14 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYX14 competed?
The extent of competition for SPE2DB25FYX14 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award